新辅助化疗的临床进展:在极端骨髓瘤中表现不佳的指标
Chandra Kumar Krishnan1, Madhusudan Reddy Karagiri2, Venkatraman Radhakrishnan3
1Department of Surgical Oncology, Cancer Institute (WIA), No: 38, Sardar Patel Road, Adyar, Chennai, 600036 India.
Indian journal of surgical oncology
|May 8, 2025
概括
骨髓瘤新辅助化疗 (NACT) 期间的临床进展表明结果不佳. 然而,在本研究中,这种进展并不是总体存活率或无病存活率的显著预测因素.
科学领域:
- 在瘤学瘤学.
- 整形外科手术 整形外科手术
- 化疗研究 化疗研究
背景情况:
- 骨髓瘤是一种恶性骨瘤.
- 新辅助化疗 (NACT) 是骨髓瘤的标准治疗方法.
- 对治疗反应的临床评估比放射学或组织学标准了解得更少.
研究的目的:
- 评估NACT期间临床评估反应是否可以预测四肢骨髓瘤患者的预后.
- 分析临床进展对整体存活率 (OS) 和无病存活率 (DFS) 的影响.
主要方法:
- 在2000年至2018年期间,对骨质肉瘤患者进行了以治疗意图治疗的回顾性分析.
- 在NACT期间识别患有临床进展的患者.
- 临床进展和没有临床进展的患者之间瘤结局 (OS,DFS) 的比较.
主要成果:
- 43名患者在NACT.上显示出临床进展.
- 临床进展的患者有更大的瘤,更多的截肢,并且对化疗反应不佳.
- 临床进展预测在单变量,但不是多变量分析中,OS和DFS差.
结论:
- 在NACT期间的临床进展与骨髓瘤癌症的较差瘤结果有关.
- 临床进展并不是OS或DFS的统计学上显著的独立预测因素.
- 需要进一步的多中心研究来澄清NACT期间临床进展的预后影响.
相关概念视频
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Cancer Survival Analysis
301
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
301


